Cosmos Health Inc. (COSM)
NASDAQ: COSM · IEX Real-Time Price · USD
1.240
-0.015 (-1.20%)
At close: Jul 19, 2024, 4:00 PM
1.230
-0.010 (-0.81%)
Pre-market: Jul 22, 2024, 5:31 AM EDT
Cosmos Health Revenue
Cosmos Health had revenue of $49.59M in the twelve months ending September 30, 2023. Revenue in the quarter ending September 30, 2023 was $12.82M with 6.72% year-over-year growth. In the year 2022, Cosmos Health had annual revenue of $50.35M.
Revenue (ttm)
$49.59M
Revenue Growth
-8.97%
P/S Ratio
0.42
Revenue / Employee
$486,159
Employees
102
Market Cap
21.00M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 50.35M | -5.89M | -10.48% |
Dec 31, 2021 | 56.24M | 833.33K | 1.50% |
Dec 31, 2020 | 55.41M | 15.73M | 39.65% |
Dec 31, 2019 | 39.68M | 2.59M | 6.99% |
Dec 31, 2018 | 37.08M | 7.07M | 23.56% |
Dec 31, 2017 | 30.01M | 23.26M | 344.28% |
Dec 31, 2016 | 6.76M | 6.22M | 1,165.53% |
Dec 31, 2015 | 533.80K | -7.11M | -93.01% |
Dec 31, 2014 | 7.64M | 6.74M | 746.55% |
Dec 31, 2013 | 902.37K | - | - |
Dec 31, 2012 | 0 | - | - |
Jul 30, 2011 | 0 | - | - |
Jul 30, 2010 | 0 | - | - |
Jul 31, 2009 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cumberland Pharmaceuticals | 38.83M |
Jaguar Health | 10.14M |
TRxADE HEALTH | 6.66M |
Singular Genomics Systems | 2.49M |
TherapeuticsMD | 1.20M |
Oncternal Therapeutics | 1.15M |
AIM ImmunoTech | 193.00K |
COSM News
- 3 days ago - Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units - Accesswire
- 11 days ago - Cosmos Health Advances Commercialization of CCX0722 Weight Management Solution with Completion of Pilot Production and Scale-Up Phases; Significant Step Towards Entering $143Bn Global Market - Accesswire
- 12 days ago - Cosmos Health's Cana Secures Contract Manufacturing Agreement with Australia's Humacology for up to 500,000 CBD Units Annually - Accesswire
- 20 days ago - Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products; Gains Access to More than 6,000 Stores of Leading Pharmacy and Retail Chains - Accesswire
- 24 days ago - Cosmos Health Signs Exclusive Distribution Agreement with Pharmalink for Its Sky Premium Life Nutraceuticals in the UAE; Receives Initial Purchase Order for 130,000 Units - Accesswire
- 4 weeks ago - Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent - Accesswire
- 5 weeks ago - Cosmos Health Completes Acquisition of Pelofarm's Pharmacy Distribution Network; Annual Revenue Poised to Grow by Over $5 Million - Accesswire
- 2 months ago - Cosmos Health Participated in Vitafoods Europe 2024; Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand - Accesswire